Smith+Nephew posted growth in all segments of its orthopedics business in the second quarter.
Spinal Tech
Medical device company MirRus raised $65 million in a round of funding for its Rhenium-based spine devices and heart disease treatment development, the company said July 27.
Spine-facing medical technology company Carlsmed is collaborating with the International Spine Study Group Foundation to collect surgical data on personalized interbody devices.
NuVasive's net sales in the second quarter increased 44.8 percent year over year to $294.8 million, and clinical evaluations of its Pulse spine system got underway in Europe.
Stryker plans to hone in on smaller mergers and acquisitions as part of its strategy for short-term growth, according to CEO Kevin Lobo.
Degenerative disc disease patients who underwent total disc replacement with the ActivL Artificial Disc had better outcomes than patients who received the ProDisc-L, according to a study by Aesculap Implant Systems.
NuVasive's newest spine implant and four more updates from device companies in the last week:
Stryker posted $1.6 billion in net sales for its orthopedics business in the second quarter, and the company saw growth across all orthopedic procedure types.
The wife of an Indiana man who died of tuberculosis after receiving Aziyo Biologics' recalled allograft is suing the company.
Flowood, Miss.-based Zavation Medical Products was sold to a new private-equity firm, according to a July 22 news release.
